开发PD-1阻断细胞结合体,以增强T细胞急性淋巴细胞白血病的细胞疗法

相关实验视频

Updated: Jul 8, 2025

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.3K

Quanxiao Wang1,2, Hongxing Huang1,2, Peisheng Liang1,2

  • 1Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, China.

Medical oncology (Northwood, London, England)
|December 11, 2023
PubMed
概括

新的细胞结合物通过阻断PD-1来增强癌症免疫疗法. 在临床前模型中,这些结合物显著提高了细胞因子诱导杀手 (ICIK) 细胞对T细胞急性淋巴细胞白血病 (T-ALL) 的有效性.

关键词:
ICIKIK ICIKIKICIK ICIKIK ICIKIK ICIKIK ICIKIK ICIKIK ICIKIK ICIKIK ICIKIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICIK ICICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC ICIC IC which which which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which is which免疫治疗是一种免疫疗法.一个PCC就是PCC.这是一种PD-1结合.所有的T-ALL.

更多相关视频

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

7.7K
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

328

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K